Executive summary

This systematic review reported that PBT provides favorable QOL/PRO profiles for select brain, head/neck, lung, and pediatric cancers; measures for prostate and breast cancers were more modest.

These results have implications for cost-effective cancer care and prudently designed QOL evaluation in ongoing trials.
 

Key content topics
Top cancer treatments